US Stock MarketDetailed Quotes

CADL Candel Therapeutics

Watchlist
  • 5.040
  • +0.905+21.89%
Close Nov 22 16:00 ET
  • 5.120
  • +0.080+1.59%
Post 19:56 ET
163.68MMarket Cap-2913P/E (TTM)

About Candel Therapeutics Company

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Company Profile

SymbolCADL
Company NameCandel Therapeutics
Listing DateJul 27, 2021
Issue Price8.00
Founded2002
CEODr. Paul Peter Tak, M.D.,PhD
MarketNASDAQ
Employees42
Fiscal Year Ends12-31
Address117 Kendrick Street,Suite 450
CityNeedham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02494
Phone1-617-916-5445
Websitehttp://www.candeltx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Paul Peter Tak, M.D.,PhD
  • President, Chief Executive Officer and Director
  • 1.48M
  • Charles Schoch
  • Interim Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. William Garrett Nichols, M.A.,M.D.
  • Chief Medical Officer
  • --
  • Dr. Francesca Barone, M.D.,PhD
  • Chief Scienctific Officer
  • 706.88K
  • Seshu Tyagarajan, PhD,R.A.C.
  • Chief Technical and Development Officer
  • --
  • Paul B. Manning
  • Chairman of the Board
  • 83.19K
  • Dr. Estuardo Aguilar-Cordova, M.D.,PhD
  • Director
  • 48.19K
  • Renee M. Gaeta
  • Independent Director
  • 55.69K
  • Joseph C. Papa
  • Independent Director
  • 58.19K
  • Dr. Edward J. Benz, Jr,M.D.
  • Independent Director
  • 56.19K
  • Christopher Martell
  • Independent Director
  • 67.19K
  • Dr. Diem Nguyen, M.B.A.,PhD
  • Independent Director
  • 60.69K
  • Dr. Nicoletta Loggia, PhD,R.Ph.
  • Independent Director
  • 52.76K
  • Dr. Gary J. Nabel, M.D.,PhD
  • Independent Director
  • 52.19K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.25%